LONDON, Aug. 28 (Korea Bizwire) — 84% of executives surveyed by PwC, report blockchain initiatives underway – 15% fully live. The new research from PwC – Blockchain is here. What’s your next move? – surveyed 600 executives in 15 countries and territories, on their development of blockchain and views on its potential. As blockchain rewires [...]
NEW YORK, Aug. 13 (Korea Bizwire) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for patients with solid tumor cancers, today announced that preliminary safety and efficacy data from a Phase 1/2 clinical trial of CK-101 (also known as RX518), a [...]
GERMANTOWN, Md., Aug. 9 (Korea Bizwire) — Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell technology, today announced that the U.S. Food and Drug Administration has granted orphan drug designation to NSI-189 for the treatment of Angelman syndrome. “Angelman Syndrome is a rare disease [...]
GERMANTOWN, Md., Aug. 1 (Korea Bizwire) — In a release issued yesterday by Neuralstem, Inc. (Nasdaq:CUR), please note the headline should be, “Neuralstem Announces Initiation of Phase 2 Clinical Trial of NSI-566 in Ischemic Stroke,” rather than, “Neuralstem Announces Initiation of Phase 2 Clinical Trial of NSI-189 in Ischemic Stroke,” as originally issued. The corrected release [...]
HONG KONG, CHINA, Jul. 31 (Korea Bizwire) – Vivid memories and emotions about things affect our perceptions of when they took place, but can the chance of them happening again also influence how we regard the past? Those of us who watched the Hollywood hit movie, La La Land, which focuses on a bitter-sweet love [...]
GERMANTOWN, Md., Jul. 23 (Korea Bizwire) — Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced the presentation of data at the Alzheimer’s Association International Conference in Chicago, Illinois, demonstrating that oral administration of NSI-189 in a mouse model of Alzheimer’s Disease leads to a significant amelioration and/or improvement [...]
TOKYO/SEOUL, Jul. 23 (Korea Bizwire) – Large shipping losses have declined by 38% globally over the past decade, according to Allianz Global Corporate & Specialty’s (AGCS) Safety & Shipping Review 2018, with this downward trend continuing in 2017. However, disparities remain as losses in Asia rose year-on-year with incidents in South China, Indochina, Indonesia and Philippine [...]
SAN JOSE, Calif., Jul. 18 (Korea Bizwire) — Skybox® Security, a global leader in cybersecurity management, announced today the release of its mid-year update to the Vulnerability and Threat Trends Report which analyzes vulnerabilities, exploits and threats in play. The report, compiled by the team of security analysts at the Skybox® Research Lab, aims to help [...]
EDMONTON, Alberta, Jul. 9 (Korea Bizwire) — Translational Research In Oncology (TRIO) today announced a collaboration with Novartis on its upcoming phase III clinical trial of ribociclib with endocrine therapy in the adjuvant treatment of HR-positive, HER2-negative early breast cancer (EBC). The trial will be called NATALEE (New Adjuvant TriAl with LEE). “Ribociclib in combination [...]
SEOUL, KOREA, Jul. 4 (Korea Bizwire) — South Korea’s trade growth has been predicted to surge with a significant increase by 5 points, according to data from the DHL Global Trade Barometer released by DHL, the world’s leading logistics company. The country’s overall index has increased to 74 points, from 69 points in the last [...]